Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University Hospital, Strasbourg, France |
---|---|
Information provided by: | University Hospital, Strasbourg, France |
ClinicalTrials.gov Identifier: | NCT00213798 |
The majority of lung cancer patients have a tumor-derived genetic alteration in circulating plasma DNA that could be exploited as a diagnostic tool. The aim of this study is to evaluate if plasma DNA can be used as a valuable non invasive test to monitor disease progression without assessing the tumor.
Condition | Intervention |
---|---|
Non-Small Cell Lung Carcinoma Small Cell Lung Cancer |
Procedure: Biopsy samples |
Study Type: | Interventional |
Study Design: | Screening, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
Official Title: | Detection of Plasma DNA by Allelotyping in Non Small Cell and Small Cell Lung Cancer Patients. Evolution During Treatment and Follow-up. |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Contact: Michèle Beau-Faller, MD | michele.faller@chru-strasbourg.fr |
France | |
Service de Pneumologie, Hôpital de Hautepierre | Recruiting |
STRASBOURG, France, 67098 | |
Contact: Michèle BEAU-FALLER, MD 33.3.88.12.71.79 Michele.Faller@chru-strasbourg.fr | |
Principal Investigator: Michèle BEAU-FALLER, MD | |
Sub-Investigator: Romain KESSLER, MD | |
Sub-Investigator: Emmanuel WEITZENBLUM, MD | |
Service de Pneumologie, Hôpital Civil | Recruiting |
STRASBOURG, France, 67091 | |
Contact: Gabrielle PAULI, MD 33.3.88.11.62.23 Gabrielle.Pauli@chru-strasbourg.fr | |
Sub-Investigator: Elisabeth QUOIX, MD | |
Sub-Investigator: Gabrielle PAULI, MD | |
Principal Investigator: Michèle Beau-Faller, MD | |
Service de Chirurgie Thoracique, Hôpital Civil | Recruiting |
Strasbourg, France, 67091 | |
Contact: Michèle Beau-Faller, MD michele.faller@chru-strasbourg.fr | |
Sub-Investigator: Jean-Marie WIHLM, MD | |
Sub-Investigator: Gilbert MASSARD, MD | |
Sub-Investigator: Xavier-Pierre DUCROCQ, MD | |
Sub-Investigator: Valérie HAMMERER, MD | |
Sub-Investigator: Carine METZ FAVRE, MD | |
Sub-Investigator: Mircea-Dan VASILESCU, MD | |
Service de Pneumologie, Hôpital Lyautey | Recruiting |
Strasbourg, France, 67000 | |
Contact: Michèle Beau-Faller, MD michele.faller@chru-strasbourg.fr | |
Sub-Investigator: Anita DIETEMANN, MD | |
Sub-Investigator: Bertrand MENNECIER, MD |
Principal Investigator: | Michèle BEAU-FALLER, MD | Service de Pneumologie, Hôpital de Hautepierre |
Responsible Party: | University Hospital, Strasbourg, France ( Emmanuel LAVOUE, Directeur Adjoint ) |
Study ID Numbers: | 2731 |
Study First Received: | September 13, 2005 |
Last Updated: | January 9, 2009 |
ClinicalTrials.gov Identifier: | NCT00213798 History of Changes |
Health Authority: | France: Ministry of Health |
Lung cancer plasma DNA allelotyping follow-up |
Prospective Study Non-Small Cell Lung Cancer Small Cell Lung Cancer |
Thoracic Neoplasms Carcinoma, Neuroendocrine Carcinoma Neuroendocrine Tumors Carcinoma, Small Cell Neuroectodermal Tumors Respiratory Tract Diseases Lung Neoplasms |
Lung Diseases Neoplasms, Germ Cell and Embryonal Neuroepithelioma Non-small Cell Lung Cancer Adenocarcinoma Carcinoma, Non-Small-Cell Lung Neoplasms, Glandular and Epithelial |
Thoracic Neoplasms Respiratory Tract Neoplasms Neoplasms by Histologic Type Carcinoma, Neuroendocrine Neoplasms, Nerve Tissue Neuroendocrine Tumors Carcinoma Carcinoma, Small Cell Neuroectodermal Tumors |
Neoplasms Neoplasms by Site Respiratory Tract Diseases Lung Neoplasms Neoplasms, Germ Cell and Embryonal Lung Diseases Adenocarcinoma Carcinoma, Non-Small-Cell Lung Neoplasms, Glandular and Epithelial |